药物相关死亡对美国死亡率劣势的贡献
该研究结合人类死亡率数据库和世界卫生组织数据,分析2000–2014年12个高收入国家与美国七大类死因的年龄标化死亡率,评估药物使用对预期寿命差距的贡献。结果显示2014年药物相关死亡增加占美国死亡率劣势的10–15%,在劳动年龄男性中高达38%。美国在多种死因上死亡率均高于对比国家。
要点
- 2014年药物相关死亡增加占美国死亡率劣势的10–15%。
- 劳动年龄男性中药物相关死亡增加贡献高达38%。
- 美国死亡率在广泛死因上高于对比国家。
核心结论
- 药物相关死亡仅部分解释美国死亡率劣势,美国在多种死因上死亡率均较高。
研究设计与样本
- 研究结合人类死亡率数据库和世界卫生组织数据,构建2000–2014年12个高收入国家与美国七大类死因的年龄标化死亡率。
主要发现
- 2014年药物相关死亡增加占美国死亡率劣势的10–15%。
- 劳动年龄男性中药物相关死亡增加贡献高达38%。
- 美国死亡率在广泛死因上高于对比国家。
临床怎么用
- 提示劳动年龄男性药物相关死亡是美国死亡率劣势的重要但非唯一因素,防控需关注多死因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The USA ranks last in life expectancy among high-income countries. Since 2000, excess US mortality has been particularly concentrated in the working ages, which are also the ages hardest hit by the increase in drug deaths. This study measures the effect of drug-related mortality on the gap in life expectancy between the USA and other countries. METHODS: Data from the Human Mortality Database and the World Health Organization were combined to construct age-standardized mortality rates for 2000-14 in 12 high-income countries and the USA for seven broad causes of death, including drug use. The contribution of each cause to the difference in life expectancy between the USA and the other 12 countries was estimated. RESULTS: In 2014, the increase in drug-related deaths accounted for 10-15% of the US disadvantage in mortality, but with marked differences by age group. For working-age men, the increase in drug-related deaths accounted for up to 38% of the difference. Overall, American mortality is higher than the comparison countries across a wide range of causes. CONCLUSIONS: The severity of the drug epidemic appears to be specific to the USA, but it only partly contributes to the American shortfall in mortality.
引用
- Barbieri M. The contribution of drug-related deaths to the US disadvantage in mortality. Int J Epidemiol. 2019. PMID: 30597015. doi:10.1093/ije/dyy288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。